HR 8630 · 119th Congress

PEAT Act of 2026

The PEAT Act of 2026 makes a targeted change to how the FDA classifies certain medications. Right now, if a drug contains any protein—even one that doesn't actually do anything medically useful—the FDA treats the entire drug as a "biological product," which triggers stricter regulatory requirements and higher costs.…

Sponsor

Rulli, Michael A. (R-Ohio)

Introduced

2026-04-30

Policy area

Health